High tide of cosmetic gynaecology: The practice changer
Cosmetic Gynaecology, the fastest-growing speciality globally, is an area of special interest that covers a variety of procedures that includes...
Read moreDetails NEWSFLASH
No Content Available
Next
Prev
FeaturedStories
CountryReport
ProductFocus
KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer
Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable colorectal cancer (MSS-CRC) Company closed...
Read moreDetailsDosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with...
Read moreDetailsRare diseases – spinal muscular atrophy
Spinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting because of loss of motor neurons due to...
Read moreDetailsAstellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer
Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with...
Read moreDetailsMedical
KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer
Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable colorectal cancer (MSS-CRC) Company closed...
Read moreDetailsDosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with...
Read moreDetailsRare diseases – spinal muscular atrophy
Spinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting because of loss of motor neurons due to...
Read moreDetailsPharmaceutical
Optometry
Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with...
Rare diseases – spinal muscular atrophy
Spinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting because of loss of motor neurons due to...
Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation
Complement Therapeutics has announced that CTx001, its gene therapy for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), has...
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White...
Dental
Rare diseases – spinal muscular atrophy
Spinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting because of loss of motor neurons due to...
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White...
Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar
8 December 2024, Doha, Qatar – A groundbreaking study by Sidra Medicine, a member of Qatar Foundation, has been published...
Featured Tag
KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer
Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable colorectal cancer (MSS-CRC) Company closed...
Rare diseases – spinal muscular atrophy
Spinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting because of loss of motor neurons due to...
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White...
Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic
Healthcare’s staffing challenge stems from mismatch rather than absolute shortage. Systems should redesign roles, modernise job classes and expand team-based...
Sponsored Posts
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White...
Read moreDetails
Expert Announcements
PlasticSurgeries
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White...
UAE’s vision for longevity in focus at Arab Health’s Future Health Summit
Dubai, United Arab Emirates, 23 January 2024: With business intelligence firm Grand View Research anticipating that the global longevity and...
GCE MEDICAL BRINGS FULL GLOBAL SUITE OF GAS CONTROL EQUIPMENT TO ARAB HEALTH MEDICAL EXPO
Zug, Switzerland – GCE Medical, an ESAB Corporation brand, launched the industry’s first full global offering of medical gas control...
MedicalTourism
Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer
Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with...
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White...
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism
Abu Dhabi, United Arab Emirates. February 27, 2025: Cleveland Clinic Abu Dhabi, part of the M42 group, has recorded a...